Systemic inflammation and oxidative stress post‐lung resection: Effect of pretreatment with N‐acetylcysteine

N‐acetylcysteine has been used to treat a variety of lung diseases, where is it thought to have an antioxidant effect. In a randomized placebo‐controlled double‐blind study, the effect of N‐acetylcysteine on systemic inflammation and oxidative damage was examined in patients undergoing lung resection, a human model of acute lung injury.

[1]  Kevin J Anstrom,et al.  Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.

[2]  L. Raiteri,et al.  Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. , 2014, The Lancet. Respiratory medicine.

[3]  M. Hind,et al.  Human models of acute lung injury , 2011, Disease Models & Mechanisms.

[4]  M. Griffiths,et al.  Biomarkers of lung injury after one‐lung ventilation for lung resection , 2011, Respirology.

[5]  Roger Williams,et al.  Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality , 2009, Hepatology.

[6]  So Ri Kim,et al.  Impact of oxidative stress on lung diseases , 2009, Respirology.

[7]  P. Goldstraw,et al.  The mortality from acute respiratory distress syndrome after pulmonary resection is reducing: a 10-year single institutional experience. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  C. Hales,et al.  Oxidant stress mediates inflammation and apoptosis in ventilator‐induced lung injury , 2008, Respirology.

[9]  N. Gedik,et al.  Silymarin, the antioxidant component of Silybum marianum, prevents sepsis-induced acute lung and brain injury. , 2008, The Journal of surgical research.

[10]  G. Verleden,et al.  N-acetyl cysteine pre-treatment attenuates inflammatory changes in the warm ischemic murine lung. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  L. Papazian,et al.  Protective Ventilation Influences Systemic Inflammation after Esophagectomy: A Randomized Controlled Study , 2006, Anesthesiology.

[12]  S. Katsaragakis,et al.  The degree of oxidative stress is associated with major adverse effects after lung resection: a prospective study. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  M. Decramer,et al.  Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial , 2005, The Lancet.

[14]  S. Katsaragakis,et al.  Postresectional pulmonary oxidative stress in lung cancer patients. The role of one-lung ventilation. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[15]  T. D’amico,et al.  Acute Lung Injury and Acute Respiratory Distress Syndrome After Pulmonary Resection , 2004, Seminars in cardiothoracic and vascular anesthesia.

[16]  R. Effros.  Exhaled breath condensate acidification in acute lung injury. , 2004, Respiratory medicine.

[17]  B. Ouyang,et al.  Intracellular glutathione in stretch‐induced cytokine release from alveolar type‐2 like cells , 2004, Respirology.

[18]  T. Szakmany,et al.  Lack of Effect of Prophylactic N-acetylcysteine on Postoperative Organ Dysfunction following Major Abdominal Tumour Surgery: A Randomized, Placebo-controlled, Double-blinded Clinical Trial , 2003, Anaesthesia and intensive care.

[19]  J. Estrela,et al.  In vivo antioxidant treatment protects against bleomycin‐induced lung damage in rats , 2003, British journal of pharmacology.

[20]  P. Yap,et al.  Acute phase responses following minimal access and conventional thoracic surgery. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[21]  A. Arifi,et al.  VATS lobectomy reduces cytokine responses compared with conventional surgery. , 2000, The Annals of thoracic surgery.

[22]  A. D. de Gaudio,et al.  The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. , 2000, American journal of respiratory and critical care medicine.

[23]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[24]  T. Evans,et al.  Acute lung injury and acute respiratory distress syndrome after pulmonary resection. , 2000, The Annals of thoracic surgery.

[25]  J. Morrow,et al.  The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation. , 1999, Drug metabolism reviews.

[26]  Z. Molnár,et al.  N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study. , 1999, Critical care medicine.

[27]  T. Evans,et al.  Postoperative lung injury and oxidative damage in patients undergoing pulmonary resection. , 1998, The European respiratory journal.

[28]  Z. Molnár,et al.  The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients , 1998, Intensive Care Medicine.

[29]  P. Suter,et al.  Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study. , 1997, Journal of critical care.

[30]  G. Bernard,et al.  A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. , 1997, Chest.

[31]  K. Reinhart,et al.  Influence of N‐acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double‐blind study , 1994, Critical care medicine.

[32]  T. Evans,et al.  Oxidative damage to plasma proteins in adult respiratory distress syndrome. , 1994, Free radical research.

[33]  P. Herlevsen,et al.  Antioxidant treatment with N‐acetylcysteine during adult respiratory distress syndrome: A prospective, randomized, placebo‐controlled study , 1992, Critical care medicine.

[34]  M. Griffiths,et al.  Exhaled breath condensate detects markers of pulmonary inflammation after cardiothoracic surgery. , 2004, American journal of respiratory and critical care medicine.

[35]  A. Proudfoot,et al.  The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage , 2004, European Journal of Clinical Pharmacology.

[36]  P. Suter,et al.  N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. , 1994, Chest.